Single ketamine infusion and neurocognitive performance in bipolar depression

Pharmacopsychiatry

Volumn 48, Issue 2, 2015, Pages 78-79

  Permoda Osip, A ^a   Kisielewski, J ^a   Bartkowska Sniatkowska, A ^a   Rybakowski, J K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

bipolar depression; ketamine; neurocognitive performance

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; DOXEPIN; ESCITALOPRAM; KETAMINE; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; MOOD STABILIZER; OLANZAPINE; PAROXETINE; QUETIAPINE; SERTRALINE; TRAZODONE; VALPROIC ACID; VENLAFAXINE;

ADULT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; COGNITION; DEPRESSION; EXECUTIVE FUNCTION; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOPHARMACOTHERAPY; STROOP TEST; VERBAL MEMORY; WORKING MEMORY; AGED; BIPOLAR DISORDER; CLINICAL TRIAL; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE;

ADULT; AGED; BIPOLAR DISORDER; DEPRESSION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KETAMINE; MALE; MIDDLE AGED; PSYCHOMOTOR PERFORMANCE;

EID: 84924183071     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0034-1394399     Document Type: Article

References (14)

1. Zarate C. A. Jr, Singh J. B., Carlton P. J. et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry: 2006; 63 856 864
2. Diazgranados N., Ibrahim L., Brutsche N. E. et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry: 2010; 67 793 802
3. Rybakowski J. K. Two generations of mood stabilizers. Int J Neuropsychopharmacol: 2007; 10 709 711
4. Permoda-Osip A., Skibińska M., Bartkowska-Sniatkowska A. et al. Factors connected with efficacy of single ketamine infusion in bipolar depression (article in Polish). Psychiatr Pol: 2014; 48 35 47
5. Permoda-Osip A., Dorszewska J., Bartkowska-Sniatkowska A. et al. Vitamin B12 level may be related to the efficacy of single ketamine infusion in bipolar depression. Pharmacopsychiatry: 2013; 46 227 228
6. Rybakowski J. K., Permoda-Osip A., Skibinska M. et al. Single ketamine infusion in bipolar depression resistant to antidepressant: are neurotrophins involved? Hum Psychopharmacol: 2013; 28 87 90
7. Trivedi M. H., Greer T. L. Cognitive dysfunction in unipolar depression: implications for treatment. J Affect Disord: 2014; 152-154 19 27
8. Raust A., Bellivier F. Cognitive disturbances and bipolar depression (article in French). Encephale: 2011; 37 03 S191 S195
9. Borkowska A., Rybakowski J. K. Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar. Bipolar Disord: 2001; 3 88 94
10. Murrough J. W., Wan L. B., Iacoviello B. et al. Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response. Psychopharmacology: 2013; [epub ahead of print]
11. Shiroma P. R., Albott C. S., Johns B. et al. Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression. Int J Neuropsychopharmacol: 2014; 17 1805 1813
12. First M. B., Spitzer R. L., Gibbon M. et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). American Psychiatric Press Inc. Washington, D.C: 1996
13. Reitan R. M. The relation of the trail making test to organic brain damage. J Cons Psychol: 1958; 19 393 394
14. Stroop J. R. Studies of interference in serial verbal reactions. J Exp Psychol: 1935; 18 643 661